IEC 62133 is an international safety standard for portable sealed rechargeable cells and batteries containing non-acid electrolytes. Split into Part 1 (nickel systems) and Part 2 (lithium systems), it defines requirements and abuse tests that verify cells and battery packs operate safely under intended use and reasonably foreseeable misuse.
What is IEC 62133?
IEC 62133 is the international standard from the International Electrotechnical Commission (IEC) for the safety of portable sealed secondary (rechargeable) cells and the batteries built from them. The 2017 edition splits the standard into two parts: IEC 62133-1 covers nickel systems, and IEC 62133-2 covers lithium systems. IEC 62133-2 was further updated by Amendment 1 in 2021.
In a medical device, the standard applies at the cell and battery-pack level. It sits upstream of full-device testing. You qualify the power source against IEC 62133, then evaluate the finished device against medical electrical safety standards such as IEC 60601-1. The core idea is to show that a cell or pack tolerates routine charging, mechanical stress, and electrical faults without fire, explosion, or leakage.
Why IEC 62133 matters in medical device development
Portable and wearable medical devices increasingly run on lithium-ion cells: infusion pumps, patient monitors, glucose meters, handheld diagnostics, and home-use therapy units. A cell failure in any of these can directly injure a patient or user, so the power source carries real safety weight.
Regulators and notified bodies treat battery safety as part of the device’s overall risk profile. Demonstrating IEC 62133 compliance for the cells provides auditors and reviewers with documented evidence that the energy source has been evaluated under recognized abuse conditions. Without it, a 510(k) reviewer or an EU MDR notified body can question the safety case, delaying clearance.
There is a cost angle too. Catching a cell that fails crush or overcharge testing late, after the enclosure and PCBA are locked, forces redesign and revalidation. Qualifying the cell early keeps the program on schedule.
How IEC 62133 works
The standard sets construction requirements plus a battery of type tests that a cell or pack must pass. Testing is usually conducted by accredited battery labs, often through the IECEE CB Scheme, so a single report is recognized across markets.
Representative tests include:
- Continuous low-rate charging and overcharging of the cell or battery.
- External short circuit at specified temperatures.
- Free fall, mechanical shock, and vibration (vibration and shock were reinstated in IEC 62133-2 to align with UN 38.3 parameters).
- Crush and impact for mechanical abuse.
- Thermal abuse (high-temperature soak) and temperature cycling.
- Forced discharge of cells and, for lithium, forced internal short circuit as a design-evaluation test.
Construction clauses cover insulation, venting, terminal contacts, and the assembly of cells into packs, including protection circuitry. Amendment 1 to Part 2 tightened several conditions, such as the crush force value and the overcharge protection wording.
IEC 62133 does not stand alone. For a finished medical device, it works alongside IEC 60601-1 (medical electrical equipment safety), UN 38.3 (lithium battery transport testing), and the risk management process of ISO 14971. Software-controlled battery management ties back into IEC 62304 when firmware governs charge or protection behavior.
Common challenges and best practices
The most frequent mistake is treating the battery as a late-stage component. Teams pick a cell on capacity and size, design the enclosure around it, and then find that the cell lacks a current IEC 62133-2 report. Qualify the cell and its supplier documentation before you commit to the mechanical design.
A second issue is version drift. Many older cell certificates reference IEC 62133:2012 or the unamended 2017 text. Confirm the report reflects IEC 62133-2:2017 with Amendment 1 where your target market expects it, and check that the test temperatures match your declared charging limits.
Pack-level scope is also easy to miss. A certified cell does not automatically make a compliant battery pack. How cells are connected, the protection circuit, and the enclosure all affect the result, so the assembled pack usually needs its own evaluation. Keep the cell datasheet, the CB report, and your pack test evidence together in the design history file, and treat any cell change as a change-control event that may trigger retesting.
Frequently asked questions
IEC 62133 is not a medical device regulation by itself, so neither the FDA nor the EU MDR mandates it directly. In practice, notified bodies, test houses, and risk reviewers expect lithium or nickel cells in portable medical devices to be evaluated against IEC 60601-1 and ISO 14971, as both require the battery’s safety to be demonstrated.
IEC 62133-1 covers nickel-based chemistries, such as nickel-metal-hydride. IEC 62133-2 covers lithium chemistries, including lithium-ion and lithium-polymer. The 2017 edition split the older single standard along chemistry lines and reset both parts to the first edition. Most portable medical devices use lithium cells, so IEC 62133-2 is the part that usually applies.
UN 38.3 covers transport safety for lithium batteries, while IEC 62133-2 covers product safety in use and misuse. They overlap in mechanical tests such as vibration and shock, which is why IEC 62133-2 reinstated the use of UN 38.3 parameters. A device program usually needs both: UN 38.3 to ship the cells and IEC 62133 to support the device safety case.
No. A cell certified to IEC 62133-2 is a starting point, not the full answer. The pack adds interconnections, protection electronics, and an enclosure, all of which change safety behavior. The assembled battery pack generally needs its own evaluation against the relevant clauses before you can claim pack-level compliance.
Related terms
IEC 60601-1
ISO 14971
UN 38.3
IEC 62304
Design Verification
